MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 93 filers reported holding MEI PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -33.3% | 15,378 | +3.1% | 0.00% | – |
| Q2 2022 | $9,000 | -35.7% | 14,921 | -35.7% | 0.00% | – |
| Q1 2022 | $14,000 | -71.4% | 23,217 | +25.9% | 0.00% | – |
| Q4 2021 | $49,000 | -22.2% | 18,442 | -19.6% | 0.00% | – |
| Q3 2021 | $63,000 | +31.2% | 22,945 | +36.4% | 0.00% | – |
| Q2 2021 | $48,000 | -36.8% | 16,828 | -24.5% | 0.00% | – |
| Q1 2021 | $76,000 | +15.2% | 22,291 | -10.3% | 0.00% | – |
| Q4 2020 | $66,000 | +40.4% | 24,847 | +64.5% | 0.00% | – |
| Q3 2020 | $47,000 | -29.9% | 15,102 | -7.2% | 0.00% | – |
| Q2 2020 | $67,000 | +219.0% | 16,271 | +23.8% | 0.00% | – |
| Q1 2020 | $21,000 | -19.2% | 13,142 | +25.7% | 0.00% | – |
| Q4 2019 | $26,000 | +30.0% | 10,453 | -10.0% | 0.00% | – |
| Q3 2019 | $20,000 | – | 11,617 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |